Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
---|---|---|---|---|---|---|---|
1. | Management for improving patients' knowledge and understanding about drug allergy. | Jarernsiripornkul, N Chaipichit, N Chumworathayi, P Krska, J |
0 | ||||
2. | Patient reporting of potential adverse drug reactions: A methodological study | Jarernsiripornkul, N Krska, J Capps, PA Richards, RM Lee, A |
2002 | ||||
3. | Patient reporting of adverse drug reactions: Useful information for pain management? | N Jarernsiripornkul J Krska RME Richards PAG Capps |
2003 | ||||
4. | Prescription-Event Monitoring: New Systematic Approach of Adverse Drug Reaction Monitoring to New Drugs | Waraporn Kakaew Narumol Jarernsiripornkul |
2005 | ||||
5. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level | Tantikosoom, W Thinkhamrop, B Kiatchusakul, S Jarernsiripornkul, N Srinakarin, J Ojongpian, S |
2005 | ||||
6. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 | ||||
7. | Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs | Jarernsiripornkul, N Kakaew, W Loalukkana, W Krska, J |
2009 | ||||
8. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | Jarernsiripornkul, N Krska, J Pongmanachai, M Nasritha, N |
2009 | ||||
9. | Knowledge, Understanding of Drug Allergy and Drug Allergy Card Carrying Behavior of Drug Allergic Patients in Srinagarind Hospital | Nataporn Chaipichit Narumol Jarernsiripornkul Pansu Chumworathayi |
2009 | ||||
10. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand | Narumol Jarernsiripornkul Sudarat Chaisrisawadsuk Aporanee Chaiyakum Janet Krska |
2009 | ||||
11. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. | Narumol Jarernsiripornkul Piyanida Senacom Verawan Uchaipichat Nataporn Chaipichit Janet Krska |
2012 | ||||
12. | Retrospective study of adverse drug reactions from warfarin: patient Self-reporting | N. Jarernsiripornkul C. Kantrong S. Lawong J. Krska |
2012 | ||||
13. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 | ||||
14. | Survey of Nurses’ Roles and Attitudes towards Adverse Drug Reaction Monitoring and Reporting | Pannyada Horata Kanchanok Gniamsombat Siriluk Jaisue Narumol Jarernsiripornkul Khon Kaen 40002 Khon Kaen University |
2013 | ||||
15. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Verawan Uchaipichat Narumol Jarernsiripornkul |
2014 | ||||
16. | Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Phueanpinit, P Jarernsiripornkul, N Pongwecharak, J Krska, J |
2014 | ||||
17. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 | ||||
18. | การตระหนักถึงความปลอดภัยในการใช้ยาแก่ผู้ป่วยที่ได้รับยากลุ่ม NSAIDs ของเภสัชกรโรงพยาบาลในภาคตะวันออกเฉียงเหนือและทัศนคติต่อความจำเป็นในการให้ข้อมูลแก่ผู้ป่วย | พชรภรณ์ เผื่อนพินิจ จุราพร พงศ์เวชรักษ์ นฤมล เจริญศิริพรกุล |
2014 | ||||
19. | การสำรวจประสบการณ์การเกิดอาการไม่พึงประสงค์จากการใช้ยาของผู้ป่วยในโรงพยาบาล | อรุณโรจน์ ปัตสุรีย์ นฤมล เจริญศิริพรกุล |
2014 | ||||
20. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 | ||||
21. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 | ||||
22. | Management for improving patients’ knowledge and understanding about drug allergy | Jarernsiripornkul, N. Chaipichit, N. Chumworathayi, P. Krska, J. |
2015 | ||||
23. | Management for improving patients´ knowledge and understanding about drug allergy. Manejo para mejora del conocimiento y entendimiento de los pacientes sobre alergias a medicamentos | Narumol Jarernsiripornkul Nataporn Chaipichit Pansu Chumworathayi Janet Krska |
2015 | ||||
24. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2015 | ||||
25. | Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2015 | ||||
26. | SURVEY OF INFORMATION SOURCES ON DRUG SAFETY IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | N. Jarernsiripornkul P. Phueanpinit J. Pongwecharak J. Krska |
2015 | ||||
27. | Survey of patients' experiences and their certainty of suspected adverse drug reactions | Narumol, J Arunrot, P Krska, J |
2015 | ||||
28. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2016 | ||||
29. | Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. | Krska, J. Jarernsiripornkul, N. |
2016 | ||||
30. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. | Jarernsiripornkul, N. Chaipichit, N. Pratipanawatr, T. Uchaipichat, V. Krska, J. |
2016 | ||||
31. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 | ||||
32. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2016 | ||||
33. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pacharaporn Phueanpinit Juraporn Pongwecharak Sermsak Sumanont Janet Krska Narumol Jarernsiripornkul |
2017 | ||||
34. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study. | Narumol Jarernsiripornkul Arunrot Patsuree Janet Krska |
2017 | ||||
35. | Attitude towards usefulness of patient information leaflets among ambulatory patients | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 | ||||
36. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Kampichit, S Pratipanawatr, T Jarernsiripornkul, N |
2018 | ||||
37. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2018 | ||||
38. | Screening and prevention of non-steroidal anti-inflammatory drug risk: Doctors and hospital pharmacists' roles | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2018 | ||||
39. | Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge. | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2019 | ||||
40. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study. | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2019 | ||||
41. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand | Pongpunna, S Pratipanawatr, T Jarernsiripornkul, N |
2019 | ||||
42. | Survey of healthcare professionals’ practices, expectations, and attitudes towards provision of patient information leaflets in Thailand | Jarernsiripornkul, N Nakboon, S Anarj, K Wongtaweepkij, K |
2020 | Count | 25 | 25 | 29 | 8 |
Title | Authors | Year | Publication name | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
1. | Patient reporting of potential adverse drug reactions: A methodological study | Jarernsiripornkul, N. Krska, J. Capps, P.A.G. Lee, A. |
2002 |
British Journal of Clinical Pharmacology 3 (53), pp. 318-325 |
||||||||
2. | Patient reporting of adverse drug reactions: Useful information for pain management? | Jarernsiripornkul, N. Krska, J. Capps, P.A.G. |
2003 |
European Journal of Pain 3 (7), pp. 219-224 |
||||||||
3. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level | Thinkhamrop, B. Kiatchusakul, S. Jarernsiripornkul, N. Srinakarin, J. Ojongpian, S. |
2005 |
Journal of the Medical Association of Thailand 3 (88), pp. 399-406 |
||||||||
4. | Adverse drug reaction monitoring: Comparing doctor and patient reporting for new drugs | Jarernsiripornkul, N. Kakaew, W. Loalukkana, W. Krska, J. |
2009 |
Pharmacoepidemiology and Drug Safety 3 (18), pp. 240-245 |
||||||||
5. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | Jarernsiripornkul, N. Krska, J. Pongmanachai, M. Nasritha, N. |
2009 |
Pharmacoepidemiology and Drug Safety 9 (18), pp. 837-841 |
||||||||
6. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand | Jarernsiripornkul, N. Chaisrisawadsuk, S. Chaiyakum, A. Krska, J. |
2009 |
Pharmacy World and Science 5 (31), pp. 559-564 |
||||||||
7. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Jarernsiripornkul, N. Senacom, P. Uchaipichat, V. Chaipichit, N. Krska, J. |
2012 |
Epilepsy and Behavior 1 (24), pp. 102-106 |
||||||||
8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Chaipichit, N. Krska, J. Pratipanawatr, T. Uchaipichat, V. Jarernsiripornkul, N. |
2014 |
European Journal of Clinical Pharmacology 5 (70), pp. 607-615 |
||||||||
9. | Hospital pharmacists’ roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2014 |
International Journal of Clinical Pharmacy 6 (36), pp. 1205-1212 |
||||||||
10. | Management for improving patients’ knowledge and understanding about drug allergy | Jarernsiripornkul, N. Chaipichit, N. Chumworathayi, P. Krska, J. |
2015 |
Pharmacy Practice 1 (13), pp. |
||||||||
11. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy (), pp. 1-5 |
||||||||
12. | Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries | Chaipichit, N. Krska, J. Pratipanawatr, T. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy (), pp. |
||||||||
13. | Statin adverse effects: patients’ experiences and laboratory monitoring of muscle and liver injuries | Chaipichit, N. Krska, J. Pratipanawatr, T. Jarernsiripornkul, N. |
2015 |
International Journal of Clinical Pharmacy 2 (37), pp. 355-364 |
||||||||
14. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: A cross-sectional survey of patients in Thailand | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2016 |
Expert Opinion on Drug Safety 4 (15), pp. 417-426 |
||||||||
15. | Experiences relating to adverse drug reactions in the community: A cross-sectional survey among patients and the general public in Thailand | Krska, J. Jarernsiripornkul, N. |
2016 |
Expert Opinion on Drug Safety 3 (15), pp. 287-295 |
||||||||
16. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Jarernsiripornkul, N. Chaipichit, N. Pratipanawatr, T. Uchaipichat, V. Krska, J. |
2016 |
Pharmacoepidemiology and Drug Safety 1 (25), pp. 54-63 |
||||||||
17. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 |
International Journal of Clinical Pharmacy 5 (38), pp. 1269-1276 |
||||||||
18. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2016 |
International Journal of Clinical Pharmacy 1 (38), pp. 25-29 |
||||||||
19. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pongwecharak, J. Sumanont, S. Krska, J. Jarernsiripornkul, N. |
2017 |
Journal of Evaluation in Clinical Practice 6 (23), pp. 1387-1394 |
||||||||
20. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study | Jarernsiripornkul, N. Krska, J. |
2017 |
European Journal of Clinical Pharmacology 2 (73), pp. 223-231 |
||||||||
21. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Pratipanawatr, T. Jarernsiripornkul, N. |
2018 |
International Journal of Clinical Pharmacy 6 (40), pp. 1559-1567 |
||||||||
22. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand | Pongwecharak, J. Krska, J. Jarernsiripornkul, N. |
2018 |
Primary Health Care Research and Development 6 (19), pp. 598-604 |
||||||||
23. | Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2019 |
PLoS ONE 1 (14), pp. |
||||||||
24. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study | Jarernsiripornkul, N. Pongwecharak, J. Krska, J. |
2019 |
International Journal of Pharmacy Practice 4 (27), pp. 362-369 |
||||||||
25. | Survey of outpatients’ use and needs of patient medicine information leaflets in Thailand | Pratipanawatr, T. Jarernsiripornkul, N. |
2019 |
International Journal of Clinical Pharmacy 1 (41), pp. 141-150 |
||||||||
26. | Survey of healthcare professionals’ practices, expectations, and attitudes towards provision of patient information leaflets in Thailand | Jarernsiripornkul, N. | 2020 |
International Journal of Clinical Pharmacy 2 (42), pp. 539-548 |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | Patient reporting of potential adverse drug reactions: a methodological study. | Jarernsiripornkul, N Krska, J Capps, PA Richards, RM Lee, A |
2002 |
British journal of clinical pharmacology 3 (53), pp. 318-25 |
|
2. | Patient reporting of adverse drug reactions: useful information for pain management? | Jarernsiripornkul, N Krska, J Richards, RM Capps, PA |
2003 |
European journal of pain (London, England) 3 (7), pp. 219-24 |
|
3. | Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. | Tantikosoom, W Thinkhamrop, B Kiatchusakul, S Jarernsiripornkul, N Srinakarin, J Ojongpian, S |
2005 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 3 (88), pp. 399-406 |
|
4. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs. | Jarernsiripornkul, N Krska, J Pongmanachai, M Nasritha, N |
2009 |
Pharmacoepidemiology and drug safety 9 (18), pp. 837-41 |
|
5. | Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs. | Jarernsiripornkul, N Kakaew, W Loalukkana, W Krska, J |
2009 |
Pharmacoepidemiology and drug safety 3 (18), pp. 240-5 |
|
6. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. | Jarernsiripornkul, N Chaisrisawadsuk, S Chaiyakum, A Krska, J |
2009 |
Pharmacy world & science : PWS 5 (31), pp. 559-64 |
|
7. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. | Jarernsiripornkul, N Senacom, P Uchaipichat, V Chaipichit, N Krska, J |
2012 |
Epilepsy & behavior : E&B 1 (24), pp. 102-6 |
|
8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. | Chaipichit, N Krska, J Pratipanawatr, T Uchaipichat, V Jarernsiripornkul, N |
2014 |
European journal of clinical pharmacology 5 (70), pp. 607-15 |
|
9. | Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Jarernsiripornkul, N Pongwecharak, J Krska, J |
2014 |
International journal of clinical pharmacy 6 (36), pp. 1205-12 |
|
10. | Survey of patients' experiences and their certainty of suspected adverse drug reactions. | Narumol, J Arunrot, P Krska, J |
2015 |
International journal of clinical pharmacy 1 (37), pp. 168-74 |
|
11. | Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries. | Chaipichit, N Krska, J Pratipanawatr, T Jarernsiripornkul, N |
2015 |
International journal of clinical pharmacy 2 (37), pp. 355-64 |
|
12. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2016 |
International journal of clinical pharmacy 5 (38), pp. 1269-76 |
|
13. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. | Jarernsiripornkul, N Chaipichit, N Pratipanawatr, T Uchaipichat, V Krska, J |
2016 |
Pharmacoepidemiology and drug safety 1 (25), pp. 54-63 |
|
14. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2016 |
International journal of clinical pharmacy 1 (38), pp. 25-9 |
|
15. | Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand. | Patsuree, A Krska, J Jarernsiripornkul, N |
2016 |
Expert opinion on drug safety (), pp. 1-9 |
|
16. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2016 |
Expert opinion on drug safety 4 (15), pp. 417-26 |
|
17. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients. | Phueanpinit, P Pongwecharak, J Sumanont, S Krska, J Jarernsiripornkul, N |
2017 |
Journal of evaluation in clinical practice 6 (23), pp. 1387-1394 |
|
18. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study. | Jarernsiripornkul, N Patsuree, A Krska, J |
2017 |
European journal of clinical pharmacology 2 (73), pp. 223-231 |
|
19. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients. | Kampichit, S Pratipanawatr, T Jarernsiripornkul, N |
2018 |
International journal of clinical pharmacy 6 (40), pp. 1559-1567 |
|
20. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. | Phueanpinit, P Pongwecharak, J Krska, J Jarernsiripornkul, N |
2018 |
Primary health care research & development (), pp. 1-7 |
|
21. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 |
The International journal of pharmacy practice 4 (27), pp. 362-369 |
|
22. | Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge. | Jarernsiripornkul, N Phueanpinit, P Pongwecharak, J Krska, J |
2019 |
PloS one 1 (14), pp. e0210395 |
|
23. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand. | Pongpunna, S Pratipanawatr, T Jarernsiripornkul, N |
2019 |
International journal of clinical pharmacy 1 (41), pp. 141-150 |
|
24. | Survey of healthcare professionals' practices, expectations, and attitudes towards provision of patient information leaflets in Thailand. | Jarernsiripornkul, N Nakboon, S Anarj, K Wongtaweepkij, K |
2020 |
International journal of clinical pharmacy 2 (42), pp. 539-548 |
|
25. | Management for improving patients' knowledge and understanding about drug allergy. | Jarernsiripornkul, N Chaipichit, N Chumworathayi, P Krska, J |
Pharmacy practice 1 (13), pp. 513 |
Title | Authors | Year | Journal title | Cited count | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
< 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Total | ||||||
1. | Patient reporting of potential adverse drug reactions: a methodological study | N Jarernsiripornkul J Krska PAG Capps RME Richards A Lee |
2002 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 3.0 (53.0), pp. 318.0-325.0 |
59 | 0 | 0 | 0 | 0 | 0 | 59 | |
2. | Patient reporting of adverse drug reactions: useful information for pain management? | N Jarernsiripornkul J Krska RME Richards PAG Capps |
2003 |
EUROPEAN JOURNAL OF PAIN 3.0 (7.0), pp. 219.0-224.0 |
45 | 0 | 0 | 0 | 0 | 0 | 45 | |
3. | Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs | N. Jarernsiripornkul W. Kakaew W. Loalukkana J. Krska |
2009 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 3.0 (18.0), pp. 240.0-245.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
4. | Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs | N. Jarernsiripornkul J. Krska M. Pongmanachai N. Nasritha |
2009 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 9.0 (18.0), pp. 837.0-841.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
5. | Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand | Narumol Jarernsiripornkul Sudarat Chaisrisawadsuk Aporanee Chaiyakum Janet Krska |
2009 |
PHARMACY WORLD & SCIENCE 5.0 (31.0), pp. 559.0-564.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
6. | Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy | Narumol Jarernsiripornkul Piyanida Senacom Verawan Uchaipichat Nataporn Chaipichit Janet Krska |
2012 |
EPILEPSY & BEHAVIOR 1.0 (24.0), pp. 102.0-106.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
7. | Retrospective study of adverse drug reactions from warfarin: patient Self-reporting | N. Jarernsiripornkul C. Kantrong S. Lawong J. Krska |
2012 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 1.0 (21.0), pp. 114.0-114.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
8. | A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Verawan Uchaipichat Narumol Jarernsiripornkul |
2014 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 5.0 (70.0), pp. 607.0-615.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
9. | Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Narumol Jarernsiripornkul Juraporn Pongwecharak Janet Krska |
2014 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 6.0 (36.0), pp. 1205.0-1212.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
10. | Experiences of adverse drug effects reported by patients in ambulatory clinic | Narumol Jarernsiripornkul Nataporn Chaipichit Janet Krska Verawan Uchaipichat Thongchai Pratipanawatr |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 213.0-213.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
11. | Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 224.0-225.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
12. | Management for improving patients´ knowledge and understanding about drug allergy. Manejo para mejora del conocimiento y entendimiento de los pacientes sobre alergias a medicamentos | Narumol Jarernsiripornkul Nataporn Chaipichit Pansu Chumworathayi Janet Krska |
2015 |
Pharmacy Practice (Internet) 1.0 (13.0), pp. 0.0-0.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
13. | Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries | Nataporn Chaipichit Janet Krska Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2.0 (37.0), pp. 355.0-364.0 |
20 | 2 | 0 | 0 | 0 | 0 | 22 | |
14. | SURVEY OF INFORMATION SOURCES ON DRUG SAFETY IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | N. Jarernsiripornkul P. Phueanpinit J. Pongwecharak J. Krska |
2015 |
CLINICAL THERAPEUTICS 8.0 (37.0), pp. E36-E36 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
15. | Survey of patients' experiences and their certainty of suspected adverse drug reactions | Jarernsiripornkul Narumol Patsuree Arunrot Janet Krska |
2015 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (37.0), pp. 168.0-174.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
16. | Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2016 |
EXPERT OPINION ON DRUG SAFETY 4.0 (15.0), pp. 417.0-426.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
17. | Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand | Arunrot Patsuree Janet Krska Narumol Jarernsiripornkul |
2016 |
EXPERT OPINION ON DRUG SAFETY 3.0 (15.0), pp. 287.0-295.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
18. | Initial development and testing of an instrument for patient self-assessment of adverse drug reactions | Narumol Jarernsiripornkul Nataporn Chaipichit Thongchai Pratipanawatr Verawan Uchaipichat Janet Krska |
2016 |
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 1.0 (25.0), pp. 54.0-63.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
19. | Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2016 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 5.0 (38.0), pp. 1269.0-1276.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
20. | Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2016 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (38.0), pp. 25.0-29.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
21. | Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients | Pacharaporn Phueanpinit Juraporn Pongwecharak Sermsak Sumanont Janet Krska Narumol Jarernsiripornkul |
2017 |
JOURNAL OF EVALUATION IN CLINICAL PRACTICE 6.0 (23.0), pp. 1387.0-1394.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
22. | Public confidence in ADR identification and their views on ADRreporting: mixed methods study | Narumol Jarernsiripornkul Arunrot Patsuree Janet Krska |
2017 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 2.0 (73.0), pp. 223.0-231.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
23. | Attitude towards usefulness of patient information leaflets among ambulatory patients | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (40.0), pp. 276.0-277.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
24. | Confidence and accuracy in identification of adverse drug reactions reported by outpatients | Sirinya Kampichit Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 6.0 (40.0), pp. 1559.0-1567.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
25. | Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand | Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska Narumol Jarernsiripornkul |
2018 |
PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT 6.0 (19.0), pp. 598.0-604.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
26. | Screening and prevention of non-steroidal anti-inflammatory drug risk: Doctors and hospital pharmacists' roles | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2018 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (40.0), pp. 268.0-268.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
27. | Development and evaluation of user-tested Thai patient information leaflets for nonsteroidal anti-inflammatory drugs: Effect on patients' knowledge | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2019 |
PLOS ONE 1.0 (14.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
28. | Practices of healthcare professionals in communicating with nonsteroidal anti-inflammatory drug users in Thailand: a qualitative study | Narumol Jarernsiripornkul Pacharaporn Phueanpinit Juraporn Pongwecharak Janet Krska |
2019 |
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 4.0 (27.0), pp. 362.0-369.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
29. | Survey of outpatients' use and needs of patient medicine information leaflets in Thailand | Supawinee Pongpunna Thongchai Pratipanawatr Narumol Jarernsiripornkul |
2019 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (41.0), pp. 141.0-150.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 |
Title | Authors | Year | Journal title | ||
---|---|---|---|---|---|
1. | Prescription-Event Monitoring: New Systematic Approach of Adverse Drug Reaction Monitoring to New Drugs | Waraporn Kakaew Narumol Jarernsiripornkul |
2005 |
Srinagarind Medical Journal (20 No 4), pp. 270-275 |
|
2. | Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports | Piyanida Senacom Narumol Jarernsiripornkul Verawan Uchaipichat |
2008 |
Srinagarind Medical Journal (23 No 4), pp. 373-382 |
|
3. | Knowledge, Understanding of Drug Allergy and Drug Allergy Card Carrying Behavior of Drug Allergic Patients in Srinagarind Hospital | Nataporn Chaipichit Narumol Jarernsiripornkul Pansu Chumworathayi |
2009 |
Srinagarind Medical Journal (24 No 3), pp. 224-230 |
|
4. | Survey of Nurses’ Roles and Attitudes towards Adverse Drug Reaction Monitoring and Reporting | Pannyada Horata Kanchanok Gniamsombat Siriluk Jaisue Narumol Jarernsiripornkul Khon Kaen 40002 Khon Kaen University |
2013 |
Isan Journal of Pharmaceutical Sciences (9 No 1), pp. 29 |
|
5. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 |
Srinagarind Medical Journal (28 No 3), pp. 302-310 |
|
6. | Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions | Nataporn Chaipichit Narumol Jarernsiripornkul Verawan Uchaipichat Thongchai Pratipanawatr Janet Krska |
2014 |
Srinagarind Medical Journal (29 No 5), pp. 461-468 |
|
7. | การตระหนักถึงความปลอดภัยในการใช้ยาแก่ผู้ป่วยที่ได้รับยากลุ่ม NSAIDs ของเภสัชกรโรงพยาบาลในภาคตะวันออกเฉียงเหนือและทัศนคติต่อความจำเป็นในการให้ข้อมูลแก่ผู้ป่วย | พชรภรณ์ เผื่อนพินิจ จุราพร พงศ์เวชรักษ์ นฤมล เจริญศิริพรกุล |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 179 |
|
8. | การสำรวจประสบการณ์การเกิดอาการไม่พึงประสงค์จากการใช้ยาของผู้ป่วยในโรงพยาบาล | อรุณโรจน์ ปัตสุรีย์ นฤมล เจริญศิริพรกุล |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 183 |
Title | Authors | NRIIS type | Year | NRIIS Scholarship | ||
---|---|---|---|---|---|---|
1. | การประเมินและประยุกต์ใช้เอกสารกำกับยาสำหรับผู้ป่วยภาษาไทยในผู้ป่วยนอกและประชากรทั่วไป |
รศ.ดร. นฤมล เจริญศิริพรกุล นางสาวสุภาวิณี พงษ์พันนา นายธงชัย ประฏิภาณวัตร |
โครงการ | 2561 | ทุนงบประมาณแผ่นดินประจำปี 2561 (งบบูรณาการวิจัยและนวัตกรรม) |